NCT01401998 - ARPKD Database Study | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

September 30, 2030

Study Completion Date

December 31, 2030

Conditions

Hepato/Renal Fibrocystic DiseaseAutosomal Recessive Polycystic Kidney DiseaseJoubert SyndromeBardet Biedl SyndromeMeckel-Gruber SyndromeCongenital Hepatic FibrosisCaroli SyndromeOro-Facial-Digital Syndrome Type INephronophthisisGlomerulocystic Kidney Disease

Trial Locations (6)

19146

RECRUITING

Children's Hospital of Philadelphia, Philadelphia

20010

RECRUITING

Children's National Hospital, Washington D.C.

30322

RECRUITING

Emory, Atlanta

45229

ENROLLING_BY_INVITATION

Cincinnati Children's, Cincinnati

84108

RECRUITING

University of Utah, Salt Lake City

02115

ENROLLING_BY_INVITATION

Boston Children's, Boston

All Listed Sponsors

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Children's Hospital of Philadelphia

OTHER